|
YTHDF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.21689999999808E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.635700E-03 |
| Normal-vs-Stage2 |
1.024950E-03 |
| Normal-vs-Stage3 |
4.23590000000473E-05 |
| Normal-vs-Stage4 |
1.626520E-04 |
| Stage1-vs-Stage2 |
5.744300E-02 |
| Stage1-vs-Stage3 |
2.900200E-02 |
| Stage1-vs-Stage4 |
3.862300E-02 |
| Stage2-vs-Stage3 |
7.903800E-01 |
| Stage2-vs-Stage4 |
9.050800E-01 |
| Stage3-vs-Stage4 |
8.757400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.45870000000048E-05 |
| Normal-vs-AfricanAmerican |
2.515100E-03 |
| Normal-vs-Asian |
1.249000E-01 |
| Caucasian-vs-AfricanAmerican |
4.752000E-01 |
| Caucasian-vs-Asian |
9.661800E-01 |
| AfricanAmerican-vs-Asian |
8.192400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54410000008376E-07 |
| Normal-vs-Female |
1.476560E-01 |
| Male-vs-Female |
4.21409999999955E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.098350E-02 |
| Normal-vs-Age(41-60Yrs) |
3.964200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.038500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.794500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.828200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.788200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.931800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.802400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.106400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.066800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.945400E-01 |
| Normal-vs-Grade 2 |
1.643820E-01 |
| Normal-vs-Grade 3 |
1.80709999964002E-07 |
| Normal-vs-Grade 4 |
5.91669999661093E-08 |
| Grade 1-vs-Grade 2 |
9.006200E-01 |
| Grade 1-vs-Grade 3 |
8.703800E-02 |
| Grade 1-vs-Grade 4 |
1.946080E-02 |
| Grade 2-vs-Grade 3 |
1.60104999999966E-05 |
| Grade 2-vs-Grade 4 |
1.65119999995245E-06 |
| Grade 3-vs-Grade 4 |
2.539200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.044000E-01 |
| Normal-vs-ccB subtype |
2.02079999955806E-07 |
| ccA subtype-vs-ccB subtype |
1.06509999997506E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.79570000000174E-05 |
| Normal-vs-N1 |
2.875600E-02 |
| N0-vs-N1 |
4.125800E-01 |
|
|
